Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Transcenta
company
About
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
- 251 - 500
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $137M
- Industries
- Biopharma,Biotechnology
- Founded date
- Jan 1, 2019
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$342M
Transcenta has raised a total of
$342M
in funding over 2 rounds. Their latest funding was raised on
Nov 29, 2021 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 29, 2021 | Post-IPO Equity | — | 2 |
ARCH Venture Partners
Lilly Asia Ventures
|
— | Detail |
| Dec 23, 2020 | Series C | $105M | 1 | — | — | Detail |
| Jan 8, 2020 | Series B | $100M | 3 |
ARCH Venture Partners
|
— | Detail |
| Jan 2, 2019 | Series Unknown | $137M | 2 |
ARCH Venture Partners
Lilly Asia Ventures
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Transcenta has made 1 investments. Their most recent investment was on
Oct 16, 2017, when Digital Asset raised $40M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 16, 2017
Digital Asset
|
Series B | $40M | Blockchain | — |
Investors
Number of Lead Investors
Number of Investors
5
3
Transcenta is funded by 3 investors.
ARCH Venture Partners
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
Yes | Post-IPO Equity |
|
Lilly Asia Ventures
|
Yes | Post-IPO Equity |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
